Nalu Bio

Nalu Bio is a biotechnology company based in San Francisco that focuses on developing cannabinoid-inspired therapeutics.

The company aims to address the historical omission of the endocannabinoid system from mainstream medicine by creating non-addictive alternatives to opioids for pain management. Nalu Bio utilizes a proprietary, AI-powered platform that combines machine learning and biological modeling to accelerate drug development while ensuring safety and efficacy. The product pipeline includes prescription therapeutics and vitamins, minerals, and supplements (VMS) targeting various health conditions such as pain management, weight management, and immune disorders. Key offerings include synthetic cannabidiol (CBD) for pain and opioid addiction, THCV-based compounds for weight management, and novel chemical entities for conditions like endometriosis. Nalu Bio's innovative approach emphasizes organic synthesis to eliminate contamination risks, positioning its products for significant impact in both pharmaceutical and retail health markets.